Stanley-Laman Group’s Organon & Co OGN Stock Holding History

Stanley-Laman Group’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,074	Closed	-$195K	–	301
2025 Q1	$195K	Buy	13,074 +2,000	+18%	+$30.8K	0.03%	275
2024 Q4	$165K	Buy	+11,074	New	+$180K	0.02%	279

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Stanley-Laman Group's OGN Position: Q2 2025 in Review

Stanley-Laman Group sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 13,074 shares — an estimated $195K sold.

Stanley-Laman Group first reported a position in OGN in Q4 2024 and held it in 2 quarters. The position peaked at $195K in Q1 2025. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

Stanley-Laman Group reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
Stanley-Laman Group sold 13,074 Organon & Co shares in Q2 2025, an estimated $195K.
Stanley-Laman Group first reported a position in Organon & Co in Q4 2024 and held it in 2 quarters.
Stanley-Laman Group's Organon & Co position peaked at $195K in Q1 2025.
695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Stanley-Laman Group's 13F filing for Q2 2025, filed 29 Jul 2025.